Novel Indoline Derivatives are Effective in the Treatment of Acute Pancreatitis

author.DisplayName 1 author.DisplayName 2 author.DisplayName 1
1Department of Chemistry, Bar-Ilan University, Ramat-Gan, Israel
2Institute of Drug Research, The Hebrew University of Jerusalem, Jerusalem, Israel

In the course of investigations on our novel idoline derivatives, which have been found to display potent anti-inflammatory and antioxidant activities, previously we described their activity against acute liver failure. Herein we report promising activity for the treatment of pancreatitis. Acute pancreatitis was induced in male Balb/c mice by ip injection of cerulein (50 μg/kg), 4x1/h. Vehicle or compounds, indoline derivative AN1297 or resolvin (positive control), dissolved in saline were injected sc once, 30 min after 1st cerulein injection. The primary indication of efficacy of AN1297 against acute pancreatitis was the reduction in serum amylase at doses of 1 and 2 mg/kg by 73% and 86%. AN1297 (2 mg/kg) was also very effective in reducing all other indicators of inflammation, TNF-α, nitrotyrosine (NT), neutrophil infiltration, pancreatic damage, such as edema and necrosis, more effectively that the control drug resolvin 1 mg/kg.









Powered by Eventact EMS